Skip to main content
Erschienen in: Rheumatology International 12/2008

01.10.2008 | Original Paper

Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis

verfasst von: Yelda Bilginer, Fatih Ozaltin, Ceyla Basaran, Ali Duzova, Nesrin Besbas, Rezan Topaloglu, Seza Ozen, Aysin Bakkaloglu

Erschienen in: Rheumatology International | Ausgabe 12/2008

Einloggen, um Zugang zu erhalten

Abstract

The aim of the present study was to determine whether intima-media thickness (IMT) of the common (CCA) and internal carotid arteries (ICA) was increased due to chronic inflammation occurring in familial Mediterranean fever (FMF) patients compared to healthy controls. Erythrocyte sedimentation rate (ESR), serum C-reactive protein (CRP), serum amyloid A protein (SAA), lipid profile and homocysteine levels were examined in 70 FMF patients [median age 14 years (range 4–24)] in an attack free period and in 50 healthy controls [median age 14 years (range 4–18)]. All the patients were homozygous or compound heterozygous for MEFV mutations. IMT of both CCA and ICA was evaluated with a high resolution B-mode ultrasonography. ESR, CRP, fibrinogen and SAA levels were significantly higher in FMF patients as compared to healthy controls (P < 0.05). Intima media thickness of the common carotid artery was found to be significantly higher in FMF patients when compared to those in healthy controls [0.37 mm (0.26–0.61) vs. 0.28 mm (0.21–0.35), P < 0.001]. The median ICA-IMT was significantly increased in the patients when compared to those in the controls [0.25 mm (0.18–0.44) vs. 0.22 mm (0.10–0.26), P < 0.001]. A positive correlation between CCA-IMT and SAA levels (r = 0.24, P = 0.04) was found while ICA-IMT positively correlated with ESR (r = 0.31, P = 0.008) and fibrinogen levels (r = 0.30, P = 0.012). Intima media thickness, an early predictor of atherosclerosis, may be associated with subclinical inflammation in children with FMF. Further studies will enlighten whether these patients will be predisposed more to coronary artery disease.
Literatur
2.
Zurück zum Zitat Ben-Chetrit E (2003) Familial Mediterranean fever (FMF) and renal AA amyloidosis—phenotype–genotype correlation, treatment and prognosis. J Nephrol 16(3):431–434PubMed Ben-Chetrit E (2003) Familial Mediterranean fever (FMF) and renal AA amyloidosis—phenotype–genotype correlation, treatment and prognosis. J Nephrol 16(3):431–434PubMed
3.
Zurück zum Zitat Stojanov S, Kastner DL (2005) Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 17(5):586–599PubMedCrossRef Stojanov S, Kastner DL (2005) Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 17(5):586–599PubMedCrossRef
4.
Zurück zum Zitat Ozen S, Hoffman HM, Frenkel J, Kastner D (2006) Familial Mediterranean fever (FMF) and beyond: a new horizon. Ann Rheum Dis 65(7):961–964PubMedCrossRef Ozen S, Hoffman HM, Frenkel J, Kastner D (2006) Familial Mediterranean fever (FMF) and beyond: a new horizon. Ann Rheum Dis 65(7):961–964PubMedCrossRef
5.
Zurück zum Zitat Duzova A, Bakkaloglu A, Besbas N, Topaloglu R, Ozen S, Ozaltin F et al (2003) Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever. Clin Exp Rheumatol 21(4):509–514PubMed Duzova A, Bakkaloglu A, Besbas N, Topaloglu R, Ozen S, Ozaltin F et al (2003) Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever. Clin Exp Rheumatol 21(4):509–514PubMed
6.
Zurück zum Zitat Tunca M, Kırkali G, Soytürk M, Akar S, Pepys MB, Hawkins PN (1999) Acute phase response an evaluation of familial Mediteranean fever. Lancet 353(9162):1415PubMedCrossRef Tunca M, Kırkali G, Soytürk M, Akar S, Pepys MB, Hawkins PN (1999) Acute phase response an evaluation of familial Mediteranean fever. Lancet 353(9162):1415PubMedCrossRef
7.
Zurück zum Zitat Persson J, Forgren J, Israelsson B, Berglund G (1994) Ultrasound-determined intima-media thickness and atherosclerosis: direct and indirect validation. Arterioscler Thrombs 14(2):261–264 Persson J, Forgren J, Israelsson B, Berglund G (1994) Ultrasound-determined intima-media thickness and atherosclerosis: direct and indirect validation. Arterioscler Thrombs 14(2):261–264
8.
Zurück zum Zitat Schillinger M, Exner M, Mlekusch W, Sabeti S, Amighi J, Nikowitsch R et al (2005) Inflammation and carotid artery—risk for atherosclerosis study (ICARAS). Circulation 111(17):2203–2209PubMedCrossRef Schillinger M, Exner M, Mlekusch W, Sabeti S, Amighi J, Nikowitsch R et al (2005) Inflammation and carotid artery—risk for atherosclerosis study (ICARAS). Circulation 111(17):2203–2209PubMedCrossRef
9.
Zurück zum Zitat Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T et al (1997) Criteria for the diagnosis of Familial Mediterranean fever. Arthritis Rheum 40(10):1879–1885PubMedCrossRef Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T et al (1997) Criteria for the diagnosis of Familial Mediterranean fever. Arthritis Rheum 40(10):1879–1885PubMedCrossRef
10.
Zurück zum Zitat National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114(2 Suppl 4th Report):555–576CrossRef National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114(2 Suppl 4th Report):555–576CrossRef
11.
Zurück zum Zitat Aggoun Y, Sidi D, Levy BI, Lyonnet S, Kachaner J, Bonnet D (2000) Mechanical properties of the common carotid artery in Williams syndrome. Heart 84(3):290–293PubMedCrossRef Aggoun Y, Sidi D, Levy BI, Lyonnet S, Kachaner J, Bonnet D (2000) Mechanical properties of the common carotid artery in Williams syndrome. Heart 84(3):290–293PubMedCrossRef
12.
Zurück zum Zitat Litwin M, Trelewicz J, Antoniewicz J, Wawer ZT, Wierzbicka A, Grenda R et al (2004) Intima media thickness and arterial elasticity in hypertensive children: controlled study. Pediatr Nephrol 19(7):767–774PubMedCrossRef Litwin M, Trelewicz J, Antoniewicz J, Wawer ZT, Wierzbicka A, Grenda R et al (2004) Intima media thickness and arterial elasticity in hypertensive children: controlled study. Pediatr Nephrol 19(7):767–774PubMedCrossRef
13.
Zurück zum Zitat Lachmann HJ, Sengul B, Yavuzsen TU, Booth DR, Booth SE, Bybee A et al (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45(6):746–750CrossRef Lachmann HJ, Sengul B, Yavuzsen TU, Booth DR, Booth SE, Bybee A et al (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45(6):746–750CrossRef
14.
Zurück zum Zitat Akdogan A, Calguneri M, Yavuz B, Arslan EB, Kalyoncu U, Sahiner L et al (2006) Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. J Am Coll Cardiol 48(11):2351–2353PubMedCrossRef Akdogan A, Calguneri M, Yavuz B, Arslan EB, Kalyoncu U, Sahiner L et al (2006) Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. J Am Coll Cardiol 48(11):2351–2353PubMedCrossRef
15.
Zurück zum Zitat Sari I, Karaoglu O, Can G, Akar S, Gulcu A, Birlik M et al (2007) Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever. Clin Rheumatol 26(9):1467–1473PubMedCrossRef Sari I, Karaoglu O, Can G, Akar S, Gulcu A, Birlik M et al (2007) Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever. Clin Rheumatol 26(9):1467–1473PubMedCrossRef
16.
Zurück zum Zitat Malle E, Steinmetz A, Raynes JG (1993) Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis 102(2):131–146PubMedCrossRef Malle E, Steinmetz A, Raynes JG (1993) Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis 102(2):131–146PubMedCrossRef
17.
Zurück zum Zitat Uhlar CM, Whitehead AS (1999) Serum Amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 265(2):501–523PubMedCrossRef Uhlar CM, Whitehead AS (1999) Serum Amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 265(2):501–523PubMedCrossRef
18.
Zurück zum Zitat Badolato R, Wang JM, Murphy WJ, Lloyd AR, Michiel DF, Bausserman LL et al (1994) Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 180(1):203–209PubMedCrossRef Badolato R, Wang JM, Murphy WJ, Lloyd AR, Michiel DF, Bausserman LL et al (1994) Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 180(1):203–209PubMedCrossRef
19.
Zurück zum Zitat Qiao J-H, Xie P-Z, Fishbein MC, Kreuzer J, Drake TA, Demer LL et al (1994) Pathology of atheromatous lesions in inbred and genetically engineered mice: genetic determination of arterial calcification. Arterioscler Thromb 14(9):1480–1497PubMed Qiao J-H, Xie P-Z, Fishbein MC, Kreuzer J, Drake TA, Demer LL et al (1994) Pathology of atheromatous lesions in inbred and genetically engineered mice: genetic determination of arterial calcification. Arterioscler Thromb 14(9):1480–1497PubMed
20.
Zurück zum Zitat Meek RL, Urieli-Shoval S, Benditt EP (1994) Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A. Proc Natl Acad Sci USA 91(8):3186–3190PubMedCrossRef Meek RL, Urieli-Shoval S, Benditt EP (1994) Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A. Proc Natl Acad Sci USA 91(8):3186–3190PubMedCrossRef
21.
Zurück zum Zitat Chait A, Han YC, Oram JF, Heinecke JW (2005) Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? J Lipid Res 46(3):389–403PubMedCrossRef Chait A, Han YC, Oram JF, Heinecke JW (2005) Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? J Lipid Res 46(3):389–403PubMedCrossRef
22.
Zurück zum Zitat Liao F, Lusis AJ, Berliner JA, Fogelman AM, Kindy M, deBeer MC, deBeer FC (1994) Serum amyloid A protein family: differential induction by oxidized lipids in mouse strains. Arterioscler Thromb 14(9):1475–1479PubMed Liao F, Lusis AJ, Berliner JA, Fogelman AM, Kindy M, deBeer MC, deBeer FC (1994) Serum amyloid A protein family: differential induction by oxidized lipids in mouse strains. Arterioscler Thromb 14(9):1475–1479PubMed
23.
Zurück zum Zitat Mitani Y, Sawada H, Hayakawa H, Aoki K, Ohashi H, Matsumura M et al (2005) Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease. Circulation 111(1):38–43PubMedCrossRef Mitani Y, Sawada H, Hayakawa H, Aoki K, Ohashi H, Matsumura M et al (2005) Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease. Circulation 111(1):38–43PubMedCrossRef
24.
Zurück zum Zitat Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A et al (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350(14):1387–1397PubMedCrossRef Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A et al (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350(14):1387–1397PubMedCrossRef
25.
Zurück zum Zitat Fyfe AL, Rothenberg LS, deBeer FC, Cantor RM, Rotter Jl, Luis AJ (1997) Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. Circulation 96(9):2914–2919PubMed Fyfe AL, Rothenberg LS, deBeer FC, Cantor RM, Rotter Jl, Luis AJ (1997) Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. Circulation 96(9):2914–2919PubMed
26.
Zurück zum Zitat Langevitz P, Livneh A, Neumann L, Buskila D, Shemer J, Amolshy D et al (2001) Prevalence of ischemic heart disease in patients with familial Mediterranean fever. Isr Med Assoc J 3(1):9–12PubMed Langevitz P, Livneh A, Neumann L, Buskila D, Shemer J, Amolshy D et al (2001) Prevalence of ischemic heart disease in patients with familial Mediterranean fever. Isr Med Assoc J 3(1):9–12PubMed
27.
Zurück zum Zitat Ozen S, Bakkaloglu A, Yilmaz E, Duzova A, Balci B, Topaloglu R et al (2003) Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheumatol 30(9):2014–2018PubMed Ozen S, Bakkaloglu A, Yilmaz E, Duzova A, Balci B, Topaloglu R et al (2003) Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheumatol 30(9):2014–2018PubMed
28.
Zurück zum Zitat Rabinovich E, Livneh A, Langevitz P, Brezniak N, Shinar E, Pras M et al (2005) Severe disease in rheumatoid arthritis patients carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis 64(7):1009–1014PubMedCrossRef Rabinovich E, Livneh A, Langevitz P, Brezniak N, Shinar E, Pras M et al (2005) Severe disease in rheumatoid arthritis patients carrying a mutation in the Mediterranean fever gene. Ann Rheum Dis 64(7):1009–1014PubMedCrossRef
29.
Zurück zum Zitat Grimaldi MP, Candore G, Vasto S, Caruso M, Caimi G, Hoffman E et al (2006) Role of the pyrin M694V (A2080G) allele in acute myocardial infarction and longevity: a study in the Sicillian population. J Leukoc Biol 79(3):611–615PubMedCrossRef Grimaldi MP, Candore G, Vasto S, Caruso M, Caimi G, Hoffman E et al (2006) Role of the pyrin M694V (A2080G) allele in acute myocardial infarction and longevity: a study in the Sicillian population. J Leukoc Biol 79(3):611–615PubMedCrossRef
Metadaten
Titel
Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial Mediterranean fever as possible predictors for atherosclerosis
verfasst von
Yelda Bilginer
Fatih Ozaltin
Ceyla Basaran
Ali Duzova
Nesrin Besbas
Rezan Topaloglu
Seza Ozen
Aysin Bakkaloglu
Publikationsdatum
01.10.2008
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 12/2008
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-008-0605-9

Weitere Artikel der Ausgabe 12/2008

Rheumatology International 12/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.